Oncology Pathology Assist at Natera

San Carlos, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, OncologyIndustries

Requirements

Bachelor’s degree, or higher, with certification as a PA or CT by the American Society of Clinical Pathology (ASCP), or equivalent board
Minimum of 7 years of experience in anatomic pathology including extensive knowledge of solid tumor pathology

Responsibilities

Assist the medical and customer service teams with the interpretation of oncology pathology reports to identify optimal samples to request when initial FFPE blocks or slides are inadequate for testing
Read and ensure accurate curation of clinical history, diagnosis, progress notes, and specimen information is entered into the Signatera sample database
Assist with devising strategies to stratify data for retrieval from the Signatera sample database and other databases as necessary
Maintain proficiency with and help organize diagnostic data according to pertinent WHO guidelines
Serve as subject matter expert to the Laboratory Director, Genetic Counseling, Customer Experience, Sales, and Clinical Trial teams for pathology reports
Assist in the identification and alert the Laboratory Director when samples may have been collected at suboptimal timepoints and/or fixative conditions
Assist Genetic Counseling and Customer Experience teams in identification and procurement of optimal additional samples, as necessary
Provide professional support for the Clinical Trial team through accurate and organized data transfer
Performs other duties as assigned

Skills

Anatomic Pathology

Solid Tumor Pathology

Pathology Reports

FFPE Blocks

WHO Guidelines

Specimen Procurement

MRD Testing

Clinical History Curation

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free